• Olsalazine Sodium: Optimizing Cancer and Inflammation Resear

  2026-06-19

  Olsalazine Sodium, a mesalamine dimer, offers robust anti-inflammatory and anti-tumor efficacy for both cancer models and xenobiotic transport studies. This guide delivers actionable protocol enhancements and troubleshooting insights, bridging evidence from colorectal cancer research and novel mosquito physiology findings.

• Letrozole as a Non-Steroidal Aromatase Inhibitor: Protocols

  2026-06-19

  Letrozole stands out as a precise, potent non-steroidal aromatase inhibitor, enabling advanced estrogen pathway modulation in breast cancer and neuroendocrine research. This guide delivers actionable protocols, troubleshooting strategies, and experimental enhancements for researchers seeking reproducible, high-quality outcomes with Letrozole from APExBIO.

• Z-VAD-FMK in Apoptosis Inhibition: Protocols and Practical I

  2026-06-18

  Z-VAD-FMK is the gold-standard irreversible pan-caspase inhibitor for dissecting apoptosis and immune regulation in cell models. This article demystifies advanced workflows, troubleshooting, and cross-domain assay design using APExBIO’s Z-VAD-FMK, connecting cutting-edge viral immunology with classic cancer research applications.

• HyperFluor 488 Goat Anti-Human IgG: Fluorescent Precision in

  2026-06-18

  The HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody is an affinity-purified, Alexa Fluor 488-conjugated polyclonal antibody optimized for sensitive detection of human immunoglobulins in diverse immunoassays. Its high specificity, robust signal amplification, and compatibility across Western blot, immunofluorescence, and flow cytometry platforms make it a preferred secondary antibody for translational and preclinical research.

• Purification of HLA-G+ EVT: Advancing Placental Immunology M

  2026-06-17

  This study introduces a robust method for isolating primary HLA-G+ extravillous trophoblasts (EVT) from human term placental tissue, enabling precise phenotyping and functional assays. By providing highly pure EVT populations, the protocol advances the modeling of maternal-fetal immune interactions and addresses longstanding limitations of trophoblast cell lines and organoids.

• TAI-1 Hec1 Inhibitor: Precision Cancer Research Workflows

  2026-06-17

  TAI-1, a first-in-class Hec1 inhibitor from APExBIO, empowers researchers to dissect mitotic regulation and apoptotic cell death in advanced cancer models with unmatched potency and specificity. This guide delivers hands-on protocols, troubleshooting insights, and data-driven comparisons to elevate your experimental outcomes across tumor types.

• CCL7+ Macrophages Drive Immune Resistance in Colorectal Canc

  2026-06-16

  This study uncovers how CCL7-expressing tumor-associated macrophages (TAMs) promote resistance to immune checkpoint inhibitors in colorectal cancer by shaping the immune microenvironment. The findings provide mechanistic insight into macrophage-driven immunotherapy resistance and highlight CCL7 as a potential target for enhancing therapeutic efficacy.

• Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP: Signal Pre

  2026-06-16

  Discover how the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP conjugated antibody advances neuroinflammatory and neuroplasticity research. This article uniquely connects rigorous immunodetection strategies with cutting-edge findings in rapid antidepressant mechanisms.

• Olsalazine Sodium: Expanding the Frontiers of Xenobiotic and

  2026-06-15

  Discover how Olsalazine Sodium, a powerful mesalamine dimer, is redefining research in inflammation, colorectal cancer models, and xenobiotic transport. This in-depth analysis explores its unique mechanistic roles and new applications beyond traditional tumor studies.

• Organic Cation Transporter Response to Alizarin Dye in Aedes

  2026-06-15

  Kennel and Rouhier's study investigates how Aedes aegypti mosquitoes process xenobiotic dyes and how exposure alters the expression of putative organic cation transporters (OCTs/OCTNs). Their work provides foundational data on transporter-mediated detoxification, highlighting potential molecular targets for innovative mosquito control strategies.

• AM251: CB1 Receptor Antagonist Workflows in Neuroscience Res

  2026-06-14

  AM251 stands out as a potent, selective CB1 receptor antagonist, enabling precision dissection of endocannabinoid signaling in complex neural and metabolic pathways. This article details actionable experimental protocols, advanced applications in cannabinoid receptor research, and troubleshooting strategies to maximize reproducibility and translational impact.

• Applied Use-Cases and Troubleshooting for Actinomycin D Work

  2026-06-13

  Actinomycin D (ActD) empowers researchers to dissect transcriptional dynamics, apoptosis induction, and DNA damage responses with unmatched precision. This guide translates advanced findings and hands-on troubleshooting into actionable protocols, maximizing data quality in both cell and animal models.

• Nullscript: Rethinking HDAC Inhibition for Translational Res

  2026-06-12

  This thought-leadership article explores Nullscript, a unique histone deacetylase inhibitor (HDACi) developed by APExBIO, highlighting its mechanistic nuances, experimental applications, and strategic implications for translational researchers. By dissecting Nullscript’s inactivity in transcriptional facilitation and its robust in vivo efficacy in cardiac models, the article offers guidance on optimizing HDAC inhibitor use across cardiac, neurodegenerative, and cancer research, while carefully distinguishing Nullscript’s capabilities from conventional HDAC inhibitors.

• Propidium Iodide: Precision DNA Intercalating Dye for Cell A

  2026-06-12

  Propidium iodide (PI) stands as the gold-standard DNA intercalating dye for robust cell viability, apoptosis, and cell cycle assays. Discover how APExBIO’s PI (B7758) empowers researchers with reproducible results, actionable troubleshooting, and workflow flexibility for both routine and advanced biomedical research.

• WDR36 Controls Human Trophectoderm Fate via Glycolytic Metab

  2026-06-11

  This study uncovers a direct mechanistic link between WDR36 and glycolytic metabolism in regulating trophectoderm differentiation during human preimplantation development. By leveraging human blastoid models and multi-omics analyses, the work provides new insights into early embryonic lineage commitment and metabolic regulation.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page